Topical application of a Rho-kinase inhibitor in rats causes penile erection
|
|
- Richard Griffith
- 6 years ago
- Views:
Transcription
1 (2004) 16, & 2004 Nature Publishing Group All rights reserved /04 $ Topical application of a Rho-kinase inhibitor in rats causes penile erection Y Dai 1,2,3, K Chitaley 1, RC Webb 1, RW Lewis 2 and TM Mills 1,2 * 1 Department of Physiology, Medical College of Georgia, Augusta, Georgia, USA; 2 Department of Surgery (Urology), Medical College of Georgia, Augusta, Georgia, USA; and 3 Department of Urology, Nanjing Drum Tower Hospital, Nanjing, China Studies from this laboratory have demonstrated that RhoA/Rho-kinase signaling mediates vasoconstriction in the penile circulation of the rat and that erection results from inhibition of this activity with Y In prior animal studies, Y was administered to the rats by intracavernous injection. To determine if topical application of the Rho-kinase inhibitor is an effective mode of delivery, Y was applied to the surface of the tunica albuginea or to the glans penis and surrounding skin in intact or castrated rats. Both sites of drug administration resulted in a marked increase in the erectile response both with and without stimulation of the autonomic innervation of the penile vasculature. Although high doses of the drug were found to reduce systemic blood pressure, topical administration of the Rho-kinase inhibitor, in appropriate doses, may have clinical value for the treatment erectile dysfunction. (2004) 16, doi: /sj.ijir Published online 12 February 2004 Keywords: erectile response; rat; Rho-kinase; RhoA; topical drug application Introduction A variety of vasoactive agents have been utilized in the pharmacological treatment of erectile dysfunction (ED). 1,2 When injected into the cavernous sinuses, drugs such as prostaglandin E1 or papaverine cause smooth muscle relaxation leading to erection of the penis. 3 Transurethral PGE1 has also been introduced as a treatment of ED, but is not widely used. 4 Phosphodiesterase 5 inhibitors, which slow the degradation of cgmp and hence facilitate erection, are effective when given orally, are convenient to use and are well tolerated. 5,6 However, despite the variety of pharmacological treatment options available, each has shortcomings and contraindications so that the search for the safest and most effective treatment for ED must continue. 7,8 It has recently been demonstrated that a previously uninvestigated biochemical pathway may regulate *Correspondence: TM Mills, PhD, Department of Physiology, Medical College of Georgia, Augusta, GA , USA. tmills@mail.mcg.edu Received 4 March 2003; revised 5 March 2003; accepted 18 May 2003 smooth muscle contraction in the cavernosal circulation The results of these studies suggest that the RhoA/Rho-kinase calcium sensitization pathway is integral to the tonic contraction, which maintains the penis in the flaccid state, and that erection can result from the reduction in the activity of this pathway with the Rho-kinase inhibitor, Y This agent is a highly selective inhibitor of Rho-kinase activity. 14,15 Based on these reported findings, it was proposed that nitric oxide (NO) is a potent inhibitor of the RhoA/Rho-kinase pathway, thereby providing a mechanism by which erection can occur in the presence of strong basal vasoconstrictor activity. 16 Furthermore, inhibition of this pathway has been suggested as a potential treatment for ED. 17 In published studies in which Rho-kinase activity in the penis has been blocked with Y-27632, the drug was administered either by intracavernosal injection 10,16 or by addition to the bathing medium in in vitro experiments The present study was undertaken to determine if topical application of the Rho-kinase inhibitor, Y-27632, was also effective at enhancing the erectile response in laboratory rats. Included in these experiments were groups of normal intact rats in which Y was applied to the tunica albuginea. In addition, the drug was applied to the glans penis and surrounding skin of castrated rats in which the erectile response is sharply suppressed.
2 Materials and methods Animals Male, Sprague Dawley rats ( g) were obtained from Harlan and maintained on a 12 h light/dark cycle with rat chow and water available ad libitum according to guidelines at the Medical College of Georgia, Augusta, Georgia, USA. In some experiments, animals were surgically castrated 7 to 14 days prior to the measurements of erectile function. Experimental design In the first series of experiments, Y was applied topically to the tunica albuginea to determine if the Rho-kinase inhibitor would cross this barrier to cause vasodilation leading to erection. In these studies, the rats were anesthetized with ketamine (87 mg/kg body weight) plus xylazine (13 mg/kg) and then a cannula was inserted into the carotid artery to permit the continuous monitoring of mean arterial pressure (MAP). Next, the penis was partially degloved by retracting the skin and fascia overlying the tunica albuginea to allow insertion of a pressure transducer cannula into the right corpus cavernosum to permit continuous monitoring of intracavernosal pressure (ICP). 16,18 Care was taken in the location of the cavernosal cannula to avoid any chance of entry of the topically applied Y around the path created by the cannula. Once these cannulae were in place, the right major pelvic ganglion (MPG) was exposed through a mid-ventral incision. With the viscera retracted, stainless-steel bipolar electrodes were placed on the MPG and, with the stimulator set at 5 V, the position of the electrodes was adjusted until the maximal ICP was achieved. During the experiment, MAP and ICP were continuously recorded on a polygraph recorder and analyzed electronically (Polyview, Grass Instrument Company). Basal ICP and MAP measurements were collected before application of the Y and without ganglionic stimulation. MAP and ICP measurements were also carried out during stepwise stimulation of the MPG (1 5 V, 5 ms duration, 12 Hz frequency with 30 s at each voltage). 19 At 10 min after application of one of the three doses of Y (100, 200, 400 mg in2ml DMSO) to the tunica albuginea of the normal intact rats, the basal and stimulated erectile responses were measured, and these values compared to the basal and stimulated responses recorded before application of the drug. In addition, ICP and MAP measurements were carried out before and after application of the DMSO vehicle only. Once these experiments had established that the Rho-kinase inhibitor readily penetrates the tunica albuginea to cause erection, a second set of studies was completed to determine if the drug would penetrate penile skin as well. In this experiment, 1000 mg Y in 2 ml DMSO or 2 ml of the DMSO vehicle was applied in castrated rats with ICP and MAP measurements carried out 20 min after application. Drugs The selective Rho-kinase inhibitor, Y-27632, generously donated by Mitsubishi Pharma, Osaka Japan, was dissolved in DMSO in order to facilitate penetration into cavernous tissue. In the normal intact rats, 100, 200 or 400 mg Y-27632/2 ml Y was applied via a micropipette over the proximal dorsal tunica albuginea. In the castrated animals, 1000 mg Y-27632/2 ml DMSO was applied to the glans penis and surrounding skin. Expression of results and statistical analyses The erectile response was computed as the ratio of ICP to the concurrently measured MAP (ICP/MAP). ICP/MAP and MAP data were analyzed using oneway analysis of variance (ANOVA) or two-way ANOVA for repeated measures with post hoc analysis by Student s Newman Keul s test. Statistical significance was set at Po0.05. Results Direct application of the Rho-kinase inhibitor Y to the tunica albuginea resulted in an increase in ICP (Figure 1). This tracing shows that within a Figure 1 Tracing of the effect of topical application of 100 mg Y (arrow) on MAP and ICP. Note that within a few minutes of application of the Rho-kinase inhibitor in 2 ml DMSO, ICP rises reaching a maximum after about 10 min. Over the same time interval, there is a minor decline in MAP. 295
3 296 Figure 2 Effects of application of Y to the tunica albuginea on the erectile response (ICP/MAP) in the rat penis. Note that 10 min after application of the DMSO vehicle or 100 mg of Y-27632, the erectile response is not significantly changed as compared to the response BEFORE application (*). However, after application of 200 and 400 mg of the Rho-kinase inhibitor, the responses are significantly increased relative to before treatment. Each bar represents the mean7s.e.m. for measurements carried out in 4 6 animals. *Po0.05. few minutes of applying 100 mg of the Rho-kinase inhibitor in 2 ml DMSO, the ICP increased with the response reaching a maximum in min. Figure 1 also demonstrates that when this concentration of Y was applied to the tunica albuginea, there was a small change in MAP. In both normal intact and castrated rats, topical application of 2 ml of the DMSO vehicle had no effect on either the basal response or the response during stimulation of the MPG. Likewise, tunical application of the low dose of Y (100 mg) failed to increase significantly the basal response (Figure 2) or the responses to ganglionic stimulation at 1 5 V (Figure 3). However, application of higher doses of the Rho-kinase inhibitor (200 or 400 mg) in intact rats significantly elevated both the basal response (Figure 2) and the response during ganglionic stimulation (Figure 3). The single exception to this was the failure of the 400 mg dose of Y to enhance the erectile response during 5 V stimulation (Figure 3). To investigate any hypotensive effect of tunical application of Y-27632, systemic blood pressure was monitored following drug application. The results in Figure 4 show that MAP declined significantly with the topical application of 200 and 400 mg ofy , although there was no significant effect after application of the DMSO vehicle or 100 mg. At both the high doses of the Rho-kinase inhibitor, MAP remained reduced for more than 30 min after topical application (not shown). Having established that Y readily crosses the tunica albuginea to dilate the cavernosal vasculature, the Rho-kinase inhibitor was applied next to Figure 3 Effects of application of Y to the tunica albuginea on the electrically stimulated (1 5 V) erectile response (ICP/MAP). At 10 min AFTER application of 100 mg Y-27632, the erectile response at all levels of electrical stimulation is not significantly different from the response at each voltage measured before application. However, in the 200 and 400 mg treatment groups, the response after drug application is significantly greater at all voltages (*) as compared to the response before application with the exception of 5 V in the 400 mg treated animals. Each bar represents the mean7s.e.m. for measurements carried out in 4 6 animals. *Po0.05. the glans penis and surrounding skin in hypogonadal animals that show severe ED with measurements of ICP and MAP 20 min after application. In the absence of ganglionic stimulation, ICP rose significantly from 771 mmhg before application to 2172 mmhg after application (Po0.05). Simultaneous measurement of MAP revealed values of mmhg declining to 8177 mmhg 20 min after application (Po0.05). Figure 5 shows that the basal erectile response and the responses at all levels of ganglionic stimulation (1 5 V) were significantly enhanced after drug application when compared to the response before the drug was applied. Discussion The results of the present study demonstrate that, when applied topically to the tunica albuginea or to the glans penis and surrounding skin, an inhibitor of Rho-kinase (Y-27632) caused penile erection. This observation extends the prior findings that intracavernous injection of Y will both initiate erection and enhance erection resulting from electrical stimulation of the MPG or administration of a NO donor drug. 10,16,20 As would be expected, the rate at which Y increased intracavernous blood pressure was greater when the drug was given by intracavernous route (maximum ICP within 5 min of injection) compared to min after topical application to the tunica albuginea or glans and
4 297 Figure 4 MAP responses to application of Y to the tunica albuginea. Comparison of MAP measurements carried out before and 10 min after application of the Rho-kinase inhibitor show no effect in the DMSO vehicle and 100 mg treated rats. However, MAP is significantly decreased in the 200 and 400 mg treated animals. Each bar represents the mean7s.e.m. for measurements carried out in 4 6 animals. *Po0.05. adjacent skin. In all instances, ICP remained elevated for more than 30 min after topical administration. Furthermore, when compared to the doses required to induce erection when Y was injected, it is clear that a greater amount of drug is required to achieve a similar erectile response when it was administered topically. Figure 1 shows that application of 100 mg Y to the tunica albuginea caused a marked rise in ICP. However, this figure also shows that after application there was a small decline in MAP. The results in Figure 4 show that at higher doses Y (200 or 400 mg) applied to the tunica albuginea, MAP was significantly suppressed, while application of the DMSO vehicle or 100 mg of the Rho-kinase inhibitor failed to reduce MAP significantly. We have previously reported that this same compound lowers blood pressure when high doses are given by intracavernous injection to normal, intact rats 10 or to severely hypertensive rats. 21 Other investigators have reported that oral administration of Y lowers blood pressure in hypertensive rats but not in normotensive animals. 14 The present study utilizes the castrated rat with 1000 mg Y applied to the glans penis and surrounding skin. As shown in Figure 5, this treatment strongly enhanced the erectile response in the castrated animals. Castration leads to a reduced erectile response based on diminished production of NO and increased sensitivity to alpha-adrenergic-mediated vasoconstriction. 25 This model was selected for these studies because the erectile response is sharply reduced compared to the response in intact animals. Furthermore, it has recently been reported that the Rho-kinase pathway is upregulated in castrated rats and that Figure 5 Comparison of the erectile response (ICP/AMP) before and 20 min after application of Y (1000 mg) to the glans penis and surrounding skin of castrated rats shows a significant stimulation (*) at all levels of ganglionic stimulation (1 5 V). Each bar represents the mean7s.e.m. for measurements carried out in four animals. *Po0.05. intracavernous injection of Y fully restores the erectile response. 26 Taken together, the results presented in this report and in prior publications support the possibility that inhibition of the RhoA/Rho-kinase signaling pathway may represent a new method for the treatment of ED. Despite the finding that some doses
5 298 of Y exert a hypotensive action when injected 10,16 or applied topically (Figure 3), further research may reveal tissue-specific isoforms of RhoA or Rho-kinase. If these isoforms are found and one proves to be unique to the urogenital system, then it is possible that selective drugs could be designed to inhibit selectively the enzyme in the cavernous circulation and not in other vascular beds. We have demonstrated that gene transfer of dominant-negative RhoA into the penis enhances erectile function. 27 This observation provides background for gene therapy in ED with respect to this cell signaling cascade. Alternatively, combining the Rho-kinase inhibitor with other ED treatment drugs could be of value. For example, a combination treatment with low doses of a PDE 5 inhibitor (such as sildenafil) with a low dose of Y may result in an enhanced erectile response while minimizing the hypotensive actions of the Rho-kinase inhibitor or adverse effects of the PDE 5 inhibitor. References 1 Pryor JL, Redmon B. New therapies and delivery mechanisms for treatment of erectile dysfunction. Int J Impot Res 2000; 12: S158 S Morales A. Developmental status of topical therapies for erectile and ejaculatory dysfunction. Int J Impot Res 2000; 12: S80 S85. 3 Bechara A et al. Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction. J Urol 1997; 157: Fulgham PF et al. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting. J Urol 1998; 160: Carson CC, Burnett AL, Levine LA, Nehra A. The efficacy of sildenafil citrate (Viagra) in clinical populations: an update. Urology 2002; 60(Suppl 2): Steers W et al. Assessment of the efficacy and safety of Viagra (sildenafil citrate) in men with erectile dysfunction during long-term treatment. Int J Impot Res 2001; 13: Meuleman EJ. Prevalence of erectile dysfunction: need for treatment? Int J Impot Res 2002; 14: S22 S28. 8 Carson CC. Erectile dysfunction in the 21st century: whom we can treat, whom we cannot treat and patient education. Int J Impot Res 2002; 14: S29 S34. 9 Chitaley K, Webb RC, Mills TM. The ups and downs of Rho-kinase and penile erection: upstream regulators and downstream substrates of Rho-kinase and their potential role in the erectile response. Int J Impot Res 2003; 15: Chitaley K et al. Antagonism of Rho-kinase stimulates rat penile erection via a nitric oxide-independent pathway. Nat Med 2001; 7: Rees RW et al. Human and rabbit cavernosal smooth muscle cells express Rho-kinase. Int J Impot Res 2002; 14: Rees RW et al. Y-27632, an inhibitor of Rho-kinase, antagonizes noradrenergic contractions in the rabbit and human penile corpus cavernosum. Br J Pharmacol 2001; 133: Wang H et al. RhoA-mediated Ca 2 þ sensitization in erectile function. J Biol Chem 2003; 277: Uehata M et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997; 389: Ishizaki T et al. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases. Mol Pharmacol 2000; 57: Mills TM et al. Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation. J Appl Physiol 2001; 91: Mills TM, Chitaley K, Lewis R. Vasoconstrictors in erectile physiology. Int J Impot Res 2001; 13: S29 S Mills T et al. Endothelin-1 induced vasoconstriction is inhibited during erection in rats. Am J Physiol 2001; 281: R476 R Somlyo AP, Somlyo AV. Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol 2000; 522: Mills TM, Chitaley K, Lewis RW, Webb RC. Nitric oxide inhibits RhoA/Rho-kinase signaling to cause erection. Eur J Pharmacol 2002; 439: Chitaley K, Webb RC, Dorrance AM, Mills TM. Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats. Int J Impot Res 2001; 13: S16 S Shabsigh R. The effects of testosterone on the cavernous tissue and erectile function. World J Urol 1997; 15: Marin R, Escrig A, Abreu P, Mas M. Androgen-dependent nitric oxide release in rat penis correlates with levels of constitutive nitric oxide synthase isoenzymes. Biol Reprod 1999; 61: Reilly CM, Zamorano P, Stopper VS, Mills TM. Androgenic regulation of NO availability in rat penile erection. J Androl 1997; 18: Reilly CM, Stopper VS, Mills TM. Androgens modulate the alpha-adrenergic responsiveness of vascular smooth muscle in the corpus cavernosum. J Androl 1997; 18: Wingard C, Johnson J, Holmes A, Prikosh A. Improved erectile function following Rho-kinase inhibition in a rat castrate model of erectile dysfunction. Am J Physiol 2003; 284: R1572 R Chitaley K et al. Adeno-associated viral gene transfer of dominant negative RhoA enhances erectile function in rats. Biochem Biophys Res Commun 2002; 298:
The effect of sildenafil on electrostimulation-induced erection in the rat model
(2002) 14, 251 255 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir The effect of sildenafil on electrostimulation-induced erection in the rat model N Ueno 1,
More informationImproved erectile function following Rho-kinase inhibition in a rat castrate model of erectile dysfunction
Articles in PresS. Am J Physiol Regul Integr Comp Physiol (February 6, 2003). 10.1152/ajpregu.00041.2003 Final Excepted Version R-00041-2003R1 Improved erectile function following Rho-kinase inhibition
More informationManaging Erectile Dysfunction
Managing Erectile Dysfunction Lewis E. Harpster MD, FACS Urology of Central PA 4/23/16 1 Objectives 1. Review physiologic mechanism of erection 2. Discuss medical management of ED 3. Discuss surgical management
More informationMALE SEXUAL DYSFUNCTION. Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara
MALE SEXUAL DYSFUNCTION Urology Division, Surgery Department Medical Faculty, University of Sumatera Utara DEFINITION The inability to achieve a satisfactory sexual relationship May involve : - inadequacy
More informationThis brief review serves as a refresher on smooth muscle physiology for those
SMOOTH MUSCLE CONTRACTION AND RELAXATION R. Clinton Webb Department of Physiology, Medical College of Georgia, Augusta, Georgia 30912 This brief review serves as a refresher on smooth muscle physiology
More informationMMM. Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS
Dr Tan & Partners MMM Vol. 1 No. 1 Morbidity & Mortality Meeting 14 th November 2014 Introduction Topic The use of Tadalafil 5mg daily for the treatment of BPH-LUTS Tadalafil 5mg daily is a well established
More informationManaging the Patient with Erectile Dysfunction: What Would You Do?
Managing the Patient with Erectile Dysfunction: What Would You Do? Florida A & M University College of Pharmacy and Pharmaceutical Sciences 42 nd Annual Clinical Symposium Wayne A. Sampson, M.D. Cross
More informationTHE RELEVANCE OF TESTOSTERONE THERAPY IN MANAGING PATIENTS WITH ERECTILE DYSFUNCTION
THE RELEVANCE OF TESTOSTERONE THERAPY IN MANAGING PATIENTS WITH ERECTILE DYSFUNCTION Aksam A. Yassin MD PhD EdD FEBU Professor of Urology & Human Sexuality Institute of Urology & Andrology, Segeberger
More informationEffects of Castration and Androgen Replacement on the Hemodynamics of Penile Erection in the Rat'
BOLOGY OF REPRODUCTON 51, 234-238 (1994) Effects of Castration and Androgen Replacement on the Hemodynamics of Penile Erection in the Rat' THOMAS M. MLLS, 2 VMENNE S. STOPPER, and VERNON T. WEDMEER Department
More informationNovel nitric oxide signaling mechanisms regulate the erectile response
(2004) 16, S15 S19 & 2004 Nature Publishing Group All rights reserved 0955-9930/04 $30.00 www.nature.com/ijir Novel nitric oxide signaling mechanisms regulate the erectile response Department of Urology,
More informationEvidence Review for Surrey Prescribing Clinical Network. Treatment: Oral and non-oral combination therapy for erectile dysfunction
Evidence Review for Surrey Prescribing Clinical Network Treatment: Oral and non-oral combination therapy for erectile dysfunction Prepared by: Linda Honey Topic Submitted by: Prescribing Clinical Network
More informationCanadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction
Canadian Undergraduate Urology Curriculum (CanUUC): Erectile Dysfunction Last reviewed July 2014 Objectives 1. Define erectile dysfunction 2. List and classify the risk factors for erectile dysfunction
More informationGUIDELINES ON PRIAPISM
GUIDELINES ON PRIAPISM (Text update March 2015) A. Salonia, I. Eardley, F. Giuliano, I. Moncada, K. Hatzimouratidis Eur Urol 2014 Feb;65(2):480-9 Introduction Priapism is a pathological condition representing
More informationIntracavernous administration of SIN-1 þ VIP in an in vivo rabbit model for erectile function
(2002) 14, 44 49 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir Intracavernous administration of SIN-1 þ VIP in an in vivo rabbit model for erectile function
More informationDifferent hemodynamic responses by color Doppler ultrasonography studies between sildenafil non-responders and responders
DOI: 10.1111/j.1745-7262.2007.00227.x www.asiaandro.com. Clinical Experience. Different hemodynamic responses by color Doppler ultrasonography studies between sildenafil non-responders and responders Shih-Tsung
More informationIC351 (tadalafil, Cialis): update on clinical experience
(2002) 14, Suppl 1, S57 S64 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir IC351 (tadalafil, Cialis): update on clinical experience 1 * 1 Urological practice,
More informationNitric Oxide in the Penis: Scientific Discoveries and Clinical Applications
Nitric Oxide in the Penis: Scientific Discoveries and Clinical Applications Arthur L. (Bud) Burnett, M.D., M.B.A., F.A.C.S. Patrick C. Walsh Professor of Urology The James Buchanan Brady Urological Institute
More informationSpring balance evaluation of the ischiocavernosus muscle
International Journal of Impotence Research (2001) 13, 294 297 ß 2001 Nature Publishing Group All rights reserved 0955-9930/01 $15.00 www.nature.com/ijir Spring balance evaluation of the ischiocavernosus
More information, David Stultz, MD. Erectile Dysfunction. David Stultz, MD September 10, 2001
Erectile Dysfunction David Stultz, MD September 10, 2001 Case Presentation A 66 year old male presents to your office requesting Viagra. He states that for the past year he has had difficulty forming
More informationNORMAL ANATOMY OF THE PENIS
NORMAL ANATOMY OF THE PENIS IOANNIS VARKARAKIS ASOSCIATE PROFESSOR OF UROLOGY 2 ND DEPT OF UROLOGY NATIONAL & KAPODISTRIAN UNIVERSITY OF ATHENS PENILE GROSS ANATOMY 3 ERECTILE COLUMNS TWO CORPORA CAVERNOSA
More informationGuidelines, Policies and Statements. Guidelines for Penile Colour Duplex Ultrasound Examination
Guidelines, Policies and Statements Guidelines for Penile Colour Duplex Ultrasound Examination Disclaimer and Copyright The ASUM Standards of Practice Board have made every effort to ensure that this Guideline/Policy/Statement
More informationfor ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology
Tadalafil 5 mg once daily for ED and LUTS/BPH Pierre Sarkis, M.D. Assistant Professor Fellow of the European Board of Urology Why this conference? Not promotional but educational The pharmacist regularly
More informationDisclosure Slide. Dr Michael Gillman IMPOTENCE ERECTILE DIFFICULTIES. Do Men Really Care??? 15/10/2014 ASSESSMENT OF ERECTILE DYSFUNCTION
ASSESSMENT OF ERECTILE DYSFUNCTION Dr Michael Gillman St Andrews Hospital North St Specialist Suites Mater Hospital 3 rd Floor Mater Private Clinic Wesley Hospital Suite 5 Level 9 Evan Thomson Bld Cleveland-
More informationLong-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis
(2003) 15, 318 322 & 2003 Nature Publishing Group All rights reserved 0955-9930/03 $25.00 www.nature.com/ijir Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction
More informationERECTION MISDIRECTION: PENILE REHABILITATION & TREATMENTS FOR ERECTILE DYSFUNCTION. Gregory Harochaw Pharmacy Manager Tache Pharmacy (204)
ERECTION MISDIRECTION: PENILE REHABILITATION & TREATMENTS FOR ERECTILE DYSFUNCTION Gregory Harochaw Pharmacy Manager Tache Pharmacy (204) 233-3469 Nerve Function After careful prostatectomy where the erectile
More informationSponsored by. Schering. Sidney Glina
Sponsored by Schering Sidney Glina Testosterone and erectile dysfunction Sidney Glina Keywords Androgen Hormone replacement therapy Hypogonadism Impotence Testosterone Abstract The role of testosterone
More informationTestosterone and PDE5 inhibitors in the aging male
Testosterone and PDE5 inhibitors in the aging male Francesco Romanelli Department of Experimental Medicine Medical Pathophysiology, Food Science and Endocrinology Section Sapienza University of Rome 3005
More informationSidney Glina Faculdade de Medicina do ABC Instituto H. Ellis Editor-in-Chief of the International Brazilian Journal of Urology
Sidney Glina Faculdade de Medicina do ABC Instituto H. Ellis Editor-in-Chief of the International Brazilian Journal of Urology (www.intbrazjurol.com.br) glinas@terra.com.br Conflict of Interest: In the
More informationTestosterone therapy in erectile dysfunction
The Aging Male 2004;7:312 318 Testosterone therapy in erectile dysfunction R. Department of Urology, Columbia University, New York, USA Key words: TESTOSTERONE, TESTOGEL 1, ERECTILE DYSFUNCTION, HYPOGONADISM,
More informationSmooth muscle pathology and erectile dysfunction
(2002) 14, Suppl 1, S17 S21 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir and erectile dysfunction 1 * 1 Department of Urology, C.H.U. de Charleroi, Charleroi,
More informationThe Role of Testosterone in the Sexual Function. Luiz Otavio Torres President Elect of ISSM Belo Horizonte - Brazil
The Role of Testosterone in the Sexual Function Luiz Otavio Torres President Elect of ISSM Belo Horizonte - Brazil Hormones and Sexual Function Paraventricular Nucleus Stimuli visual Sexual Desire Melatonine
More informationErectile Dysfunction
a report by Asif Muneer, Nigel Borley and David J Ralph The St Peter s Andrology Centre, London Erectile dysfunction is a common male sexual function disorder and is defined as the inability to achieve
More informationGUIDELINES ON ERECTILE DYSFUNCTION
16 GUIDELINES ON ERECTILE DYSFUNCTION E. Wespes (chairman), E. Amar, D. Hatzichristou, Dr. F. Montorsi, J. Pryor, Y. Vardi Eur Urol 2002;41:1-5 1. Background, definition and classification Male erectile
More informationOral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction
(2000) 12, Suppl 1, S75±S80 ß 2000 Macmillan Publishers Ltd All rights reserved 0955-9930/00 $15.00 www.nature.com/ijir Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of
More informationGUIDELINES ON ERECTILE DYSFUNCTION
GUIDELINES ON ERECTILE DYSFUNCTION (Text updated March 2005) E. Wespes (chairman), E. Amar, D. Hatzichristou, K. Hatzimouratidis, F. Montorsi, J. Pryor, Y. Vardi 88 Erectile Dysfunction Eur Urol 2001;40:97-101
More informationIs there a role of radial rigidity in the evaluation of erectile dysfunction?
(2001) 13, 200±204 ß 2001 Nature Publishing Group All rights reserved 0955-9930/01 $15.00 www.nature.com/ijir Is there a role of radial rigidity in the evaluation of erectile dysfunction? JH Ku 1 *, YS
More informationREVIEW The relationship between hypogonadism and erectile dysfunction
(2008) 20, 231 235 & 2008 Nature Publishing Group All rights reserved 0955-9930/08 $30.00 www.nature.com/ijir REVIEW The relationship between hypogonadism and erectile dysfunction TIS Hwang 1,2,3 and Y-C
More information13-Oct-15 ERECTILE DYSFUNCTION. Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U
ERECTILE DYSFUNCTION Urology Subdepartement dr. Mintohardjo Naval Hospital dr. Isdiyanto Septiadi, Sp.U 1 2 3 So what is impotence or erectile dysfunction..? The persistent inability to achieve or maintain
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,500 108,000 1.7 M Open access books available International authors and editors Downloads Our
More informationPhysiology and disturbances of sexual functions Prof. Jolanta Słowikowska-Hilczer, M.D., Ph.D.
Physiology and disturbances of sexual functions Prof. Jolanta Słowikowska-Hilczer, M.D., Ph.D. Department of Andrology and Reproductive Endocrinology Medical University of Łódź, Poland SEXUALITY Sexuality
More informationSildenafil citrate improves erectile function after castration in a rat model
Sildenafil citrate improves erectile function after castration in a rat model John P. Mulhall*, Nipun Verma, Serkan Deveci, Raanan Tal*, Keith Kobylarz and Alexander Müller* *Department of Urology, Memorial
More informationMODULE 4: ERECTILE DYSFUNCTION
MODULE 4: ERECTILE DYSFUNCTION KEYWORDS: Erectile dysfunction, phosphodiesterase inhibitors, sexual dysfunction LEARNING OBJECTIVES At the end of this clerkship, the medical student will be able to: 1.
More informationReview of intraurethral suppositories and iontophoresis therapy for erectile dysfunction
(2000) 12, Suppl 4, S86±S90 ß 2000 Macmillan Publishers Ltd All rights reserved 0955-9930/00 $15.00 www.nature.com/ijir Review of intraurethral suppositories and iontophoresis therapy for erectile dysfunction
More informationERECTILE DYSFUNCTION TREATMENTS
ERECTILE DYSFUNCTION TREATMENTS Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage
More informationOnset and duration of action of sildena l citrate for the treatment of erectile dysfunction
Onset and duration of action of sildena l citrate for the treatment of erectile dysfunction Ian Eardley, 1 Peter Ellis, 2 Mitradev Boolell 2 & Maria Wulff 2 1 Department of Urology, St James University
More informationClinic for urology, pediatric urology and andrology. Penile diseases. Dr. Arne Hauptmann
Clinic for urology, pediatric urology and andrology JUSTUS- LIEBIG UNVERISTY GIESSEN Penile diseases Dr. Arne Hauptmann Clinic for urology, pediatric urology and andrology University Giessen und Marburg
More informationInformation for Patients. Priapism. English
Information for Patients Priapism English Table of contents What is priapism?... 3 What causes priapism?... 3 Diagnosing priapism... 3 Treating priapism... 4 Conservative, first- and second-line treatments...
More informationPharmacology - Problem Drill 11: Vasoactive Agents
Pharmacology - Problem Drill 11: Vasoactive Agents Question No. 1 of 10 1. Vascular smooth muscle contraction is triggered by a rise in. Question #01 (A) Luminal calcium (B) Extracellular calcium (C) Intracellular
More informationMale Pelvic Health following Pelvic Surgery
Male Pelvic Health following Pelvic Surgery Radical Pelvic Surgery Associated Sexual Dysfunction Pathophysiology Post Radical Prostatectomy (RP) Sexual Dysfunctions Erectile dysfunction (ED) Anejaculation
More informationErectile Dysfunction Medical Treatment
1 Erectile Dysfunction Medical Treatment Alireza Ghoreifi Assistant of Urology Mashhad University of Medical Sciences March 2012 2 Treatment of ED Unknown cases of ED First-line therapy Second-line therapy
More informationDesign and Evaluation of Nitrosylated -Adrenergic Receptor Antagonists as Potential Agents for the Treatment of Impotence 1
0022-3565/99/2901-0121$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 290, No. 1 Copyright 1999 by The American Society for Pharmacology and Experimental Therapeutics Printed in
More informationChronicSildenafilImprovesErectileFunctionand Endothelium-dependent Cavernosal Relaxations in Rats: Lack oftachyphylaxis $
European Urology European Urology 47 (2005) 87 91 ChronicSildenafilImprovesErectileFunctionand Endothelium-dependent Cavernosal Relaxations in Rats: Lack oftachyphylaxis $ Delphine Behr-Roussel a, Diane
More informationBJUI OBJECTIVE CONCLUSIONS
21 THE AUTHORS; 21 Investigative Urology VIP AND ERECTILE FUNCTION IN CASTRATED RATS SHEN ET AL. BJUI Vasoactive intestinal polypeptide, an erectile neurotransmitter, improves erectile function more significantly
More informationDepartment of Urology, School of Medicine and Shu-Tien Urological Research Center, National Yang-Ming University, Taipei, Taiwan, Republic of China
(2002) 14, 139 145 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir Involvement of L-arginine=nitric oxide pathway at the paraventricular nucleus of hypothalamus
More informationDiagnosis and management of sexual dysfunction. Dr Chris Simpson Consultant Psychiatrist
Diagnosis and management of sexual dysfunction Dr Chris Simpson Consultant Psychiatrist What are we talking about? Male Erectile dysfunction Premature ejaculation Delayed ejaculation Sexual aversion Paraphilia
More informationLONG-TERM INTRACAVERNOUS THERAPY RESPONDERS CAN POTENTIALLY SWITCH TO SILDENAFIL CITRATE AFTER RADICAL PROSTATECTOMY
ADULT UROLOGY LONG-TERM INTRACAVERNOUS THERAPY RESPONDERS CAN POTENTIALLY SWITCH TO SILDENAFIL CITRATE AFTER RADICAL PROSTATECTOMY RUPESH RAINA, MILTON M. LAKIN, ASHOK AGARWAL, SANDRA AUSMUNDSON, DROGO
More informationProteomic Profiling of the Corpus Cavernosum Tissue of Rats
Proteomic Profiling of the Corpus Cavernosum Tissue of Rats By Catherine Grey Kasper Submitted in Partial Fulfillment of the Requirements for the Degree of Master of Science in Biological Sciences YOUNGSTOWN
More informationSchemi terapeutici complessi per la gestione della disfunzione erettile post trattamento del carcinoma prostatico: non solo PDE5i
Schemi terapeutici complessi per la gestione della disfunzione erettile post trattamento del carcinoma prostatico: non solo PDE5i M. Lazzeri MD-PhD Department of Urology Ist. Clinico Humanitas IRCCS Schema
More informationPriapism. Medical Student case-based learning
Priapism Medical Student case-based learning A 45 year old man presents with an erection lasting over 5 hours. What are the two major subtypes of priapism? Types of Priapism Ischemic veno-occlusive or
More informationErectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016
Erectile Dysfunction (ED) Shawn McGee M.D. CentraCare Adult and Pediatric Urology January 30 th, 2016 Erectile dysfunction: The inability to attain or maintain penile erection sufficient for satisfactory
More informationErectile Dysfunction: A Primer for Primary Care Providers
Erectile Dysfunction: A Primer for Primary Care Providers Jeanne Martin, DNP, ANP-BC Objectives 1. Understand the definition, incidence and prevalence of Erectile Dysfunction in the U.S. 2. Understand
More informationSexual Dysfunction Caused by Cancer Treatments Issues in Men. Dr Christopher Love
Sexual Dysfunction Caused by Cancer Treatments Issues in Men Dr Christopher Love Urological and Prosthetic Surgeon Bayside Urology 66 Balcombe Rd., Mentone Men s Health Melbourne Level M 233 Collins St.,
More informationPro-erectile effects of the Rho-kinase inhibitor (S)-(+)-2-methyl-1- [(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the.
JPET This Fast article Forward. has not been Published copyedited and on formatted. June 23, The 2005 final version as DOI:10.1124/jpet.105.086041 may differ from this version. JPET # 86041 1 Pro-erectile
More informationRelaxation mechanisms of neferine on the rabbit corpus cavernosum tissue in vitro
Asian J Androl 2007; 9 (6): 795 800 DOI: 10.1111/j.1745-7262.2007.00321.x www.asiaandro.com. Original Article. Relaxation mechanisms of neferine on the rabbit corpus cavernosum tissue in vitro Jun Chen
More informationIs there a role for extracorporeal shock wave therapy for erectile dysfunction unresponsive to phosphodiesterase type 5 inhibitors?
DOI 10.1007/s00345-016-1899-y LETTER TO THE EDITOR Is there a role for extracorporeal shock wave therapy for erectile dysfunction unresponsive to phosphodiesterase type 5 inhibitors? Zi jun Zou 1 Zhi hong
More informationSelect Prostaglandins
Select Prostaglandins Epoprostenol Sodium (Prostacyclin) Alprostadil (Caverject, Muse) Epoprostenol Sodium (Prostacyclin) Alprostadil (Caverject, Muse) Promoted in conjunction with Pharmaceutical Materials
More informationA step by step tutorial on PD surgery: Incision and Grafting
A step by step tutorial on PD surgery: Incision and Grafting Wayne J.G. Hellstrom, MD, FACS President Elect, International Society of Sexual Medicine Professor of Urology Chief, Section of Andrology Tulane
More informationRAPID COMMUNICATION. Vascular Reactivity in Isolated Lungs of Rats with Spontaneous Systemic Hypertension
Physiol. Res. 40:367-371,1991 RAPID COMMUNICATION Vascular Reactivity in Isolated Lungs of Rats with Spontaneous Systemic Hypertension V. HAMPL, J. HERGET Department of Physiology, 2nd Medical School,
More informationASSESSMENT OF PREMATURE EJACULATION AND ERECTILE DYSFUNCTION
ASSESSMENT OF PREMATURE EJACULATION AND ERECTILE DYSFUNCTION Dr Michael Gillman St Andrews Hospital Wickham Terrace Spring Hill Mater Private Clinic, South Brisbane Shore St West Medical Centre, Cleveland
More informationEffect of chronic hypoxia on penile erectile function in rats
Effect of chronic hypoxia on penile erectile function in rats D.P. Yu 1, X.H. Liu 2 and A.Y. Wei 3 1 Department of Urology, The First People s Hospital of Jining City in Shandong Province, Jining, Shandong,
More informationCardiovascular Parameter Changes in Patients With Erectile Dysfunction Using Pde-5 Inhibitors: A Study With Sildenafil and Vardenafil
Journal of Andrology, Vol. 25, No. 4, July/August 2004 Copyright American Society of Andrology Cardiovascular arameter Changes in atients With Erectile Dysfunction Using de-5 Inhibitors: A Study With Sildenafil
More informationSUPPLEMENTAL DATA. Lumen area ( m 2 )
Elastin Lumen area ( m 2 ) Media to lumen ratio (x1) H.E. Medium thickness ( m) Medium area ( m 2 ) SUPPLEMENTAL DATA A (Bmal1 flox/flox ) (SM-Bmal1 -/- ) B 1 8 8 6 6 4 4 2 2 1µm 5 8 4 6 3 2 4 1 2 Supplemental
More informationBJUI. Study Type Diagnostic (case series) Level of Evidence 4 OBJECTIVE CONCLUSIONS
2008 The Authors. Journal compilation 2008 BJU International Sexual Medicine PARK et al. BJUI BJU INTERNATIONAL Why a combined intracavernosal injection with trimix and oral sildenafil is reliable therapy
More informationTestosterone Regulates PDE5 Expression and in vivo Responsiveness totadalafil in Rat Corpus Cavernosum
European Urology European Urology 47 (2005) 409 416 Testosterone Regulates PDE5 Expression and in vivo Responsiveness totadalafil in Rat Corpus Cavernosum Xin-hua Zhang a,1, Annamaria Morelli a,1, Michaela
More informationIndex 489. dysfunction,
Index 485 Index A -Adrenergic receptors, 1-blockers and sexual side effects, 162, 163 erection role, 22, 23 ACE inhibitors, see Angiotensin-converting enzyme inhibitors Acetazolamide, sexual side effects,
More informationWITH ERECTILE DYSFUNCTION
Clinical Urology International Braz J Urol Vol. 29 (4): 320-326, July - August, 2003 Official Journal of the Brazilian Society of Urology OF PATIENTS WITH ERECTILE DYSFUNCTION JOAQUIM A. CLARO, SÉRGIO
More informationSexual dysfunction in men with diabetes
Article Sexual dysfunction in men with diabetes Lesley Mills Citation: Mills L (2015) Sexual dysfunction in men with diabetes. Journal of Diabetes Nursing 19: 332 8 Article points 1. Sexual dysfunction
More informationsignificantly less than for CCP, which was significantly less than for venous outflow.
Journal of Phy8iology (1988), 400, pp. 75-88 75 With 6 text-fitgures Printed in Great Britain VASCULAR CHANGES DURING PENILE ERECTION IN THE DOG BY C. J. CARATI, K. E. CREED* AND E. J. KEOGH From the Impotence
More informationProcedures to address priapism
Procedures to address priapism INTRODUCTION Priapism is a urologic emergency that can lead to penile ischemia if not promptly addressed. It is generally defined as an erection lasting longer than 4 hours
More informationAnatomy & Physiology: Testis Penis. Hosam Serag ST7 Urology University Hospital of Wales
Anatomy & Physiology: Testis Penis Hosam Serag ST7 Urology University Hospital of Wales Testis Dimensions: 4 to 5 cm long 3 cm wide 2.5 cm deep volume of 30 ml Prader Orchidometer Layers Visceral tunica
More informationErectile dysfunction (ED) is the inability to obtain or maintain an erection satisfactory
Determining the Feasibility of Managing Erectile Dysfunction in Humans With Placental-Derived Stem Cells Jason A. Levy, OMS IV, MS; Melissa Marchand, PA-C; Leanne Iorio, OMS II; Walquiria Cassini; and
More informationA Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction
A Proposed Study of Hyperbaric Oxygen Therapy Following Radical Prostatectomy: Effects on Erectile Dysfunction Anthony J. Bella MD, FRCSC Division of Urology, Department of Surgery and Department of Neuroscience
More informationJohanna Lucy Hannan. A thesis submitted to the Department of Pharmacology & Toxicology in conformity with
EVIDENCE LINKING THE STRUCTURE AND FUNCTION OF THE INTERNAL PUDENDAL ARTERY TO ERECTILE FUNCTION: IMPACT OF AGING, HYPERTENSION, ANTIHYPERTENSIVE TREATMENTS AND LIFESTYLE MODIFICATIONS by Johanna Lucy
More informationEndothelial Nitric Oxide Synthase Keeps Erection Regulatory Function Balance in the Penis
european urology 51 (2007) 1732 1740 available at www.sciencedirect.com journal homepage: www.europeanurology.com Sexual Medicine Endothelial Nitric Oxide Synthase Keeps Erection Regulatory Function Balance
More informationPhosphodiesterase Type 5 Inhibitors Quantity Limit Program Summary
Phosphodiesterase Type 5 Inhibitors Quantity Limit Program Summary FDA APPROVED INDICATIONS AND DOSAGE 1-4,23 Agent FDA Approved Dosage and Administration Indication Cialis (tadalafil) (ED) ED; As needed:
More informationHigh dose sildenafil citrate as a salvage therapy for severe erectile dysfunction
(2002) 14, 533 538 ß 2002 Nature Publishing Group All rights reserved 0955-9930/02 $25.00 www.nature.com/ijir High dose sildenafil citrate as a salvage therapy for severe erectile dysfunction 1 * 1 Australian
More informationERECTILE DYSFUNCTION. & Current Therapies. GP Conference, Rotorua 7-10 June 2012
ERECTILE DYSFUNCTION & Current Therapies GP Conference, Rotorua 7-10 June 2012 Jan Burns & Annie Woodsford Jan: EN, RCpN, BHSc, RPN (USA),MHSc, Member of the Sexual Medicine Society Urology Nurse Specialist
More informationIntroduction. Original Article: Clinical Investigation. Lu Sun, 1,3 Fang-Li Peng, 2 Zhi-Ling Yu, 1 Cai-Ling Liu 1 and Jun Chen 3.
bs_bs_banner International Journal of Urology (2014) 21, 1263 1267 doi: 10.1111/iju.12564 Original Article: Clinical Investigation Combined sildenafil with vacuum erection device therapy in the management
More informationEffects and Mechanism of Action of a Tribulus terrestris Extract on Penile Erection
www.kjurology.org http://dx.doi.org/10.4111/kju.2013.54.3.183 Sexual Dysfunction Effects and Mechanism of Action of a Tribulus terrestris Extract on Penile Erection Jungmo Do, Seemin Choi, Jaehwi Choi,
More informationhttp://noodlemaz.wordpress.com/category/science/cancer/ Outline Introduction Serious nature of Cardiovascular Disease (CVD) How to prevent CVD? The disease process Damage and plaque development Current
More informationGeorge Franklin Lasker. Approved: David W. Busija, PhD/MD (Dissertation Advisor) Barbara S. Beckman, PhD. Craig W. Clarkson, PhD
NEW APPROACHES FOR TREATMENT OF ERECTILE DYSFUNCTION IN CONDITIONS OF LOW NITRIC OXIDE FORMATION: INVESTIGATION OF RHO-KINASE INHIBITORS AND SOLUBLE GUANYLATE CYCLASE- TARGETED THERAPIES A DISSERTATION
More informationKEYWORDS: Erectile dysfunction, phosphodiesterase inhibitors, sexual dysfunction.
NATIONAL MEDICAL STUDENT CURRICULUM ERECTILE DYSFUNCTION (ED) This document was amended in July 2016 to reflect literature that was released since the original publication of this content in May 2012 and
More informationLONG-TERM EFFECT OF SILDENAFIL CITRATE ON ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY: 3-YEAR FOLLOW-UP
ADULT UROLOGY LONG-TERM EFFECT OF SILDENAFIL CITRATE ON ERECTILE DYSFUNCTION AFTER RADICAL PROSTATECTOMY: 3-YEAR FOLLOW-UP RUPESH RAINA, MILTON M. LAKIN, ASHOK AGARWAL, RAKESH SHARMA, KUSH K. GOYAL, DROGO
More information/04/ /0 Reprinted from Vol. 172, , August 2004 THE JOURNAL OF UROLOGY
0022-5347/04/1722-0658/0 Reprinted from Vol. 172, 658 663, August 2004 THE JOURNAL OF UROLOGY Printed in U.S.A. Copyright 2004 by AMERICAN UROLOGICAL ASSOCIATION DOI: 10.1097/01.ju.0000132389.97804.d7
More informationErectile dysfunction as an early sign of cardiovascular disease
(2005) 17, S19 S24 & 2005 Nature Publishing Group All rights reserved 0955-9930/05 $30.00 www.nature.com/ijir Erectile dysfunction as an early sign of cardiovascular disease 1 * 1 The EpiCenter for Sexual
More informationProerectile Effects of the Rho-Kinase Inhibitor (S)-( )-2- Methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]homopiperazine (H-1152) in the Rat Penis
0022-3565/05/3151-155 162$20.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 315, No. 1 Copyright 2005 by The American Society for Pharmacology and Experimental Therapeutics 86041/3048730
More informationIntroduction. H Porst
International Journal of Impotence Research (1997) 9, 187±192 ß 1997 Stockton Press All rights reserved 0955-9930/97 $12.00 (medicated urethral system for erection) vs intracavernous AlprostadilÐa comparative
More informationRelaxation responses of aortic rings from salt-loaded high calcium fed rats to potassium chloride, calcium chloride and magnesium sulphate
Pathophysiology 4 (1998) 275 280 Relaxation responses of aortic rings from salt-loaded high calcium fed rats to potassium chloride, calcium chloride and magnesium sulphate B.J. Adegunloye, O.A. Sofola
More informationProduct Introduction
Product Introduction 康達生命科學有限公司 Contek Life Science Co., Ltd. Red Algae Peptide Hydrolysate-EDpeptide The Next Generations of Erectile Dysfunction Cure Introduction of small peptides Erectile dysfunction
More information